![]() |
|
|
Y Chern, JY Chiou, HL Lai and MH Tsai
Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China.
We reported earlier that inhibition of adenylyl cyclase activity is a mechanism involved in desensitization of the A2a adenosine receptor- mediated cAMP response (A2a desensitization) in rat pheochromocytoma PC- 12 cells. Here, we investigated the molecular mechanism that modulates adenylyl cyclase activity during A2a desensitization. Reversible inhibition of forskolin-evoked adenylyl cyclase activity in desensitized cells occurred after incubation with an A2a-selective adenosine agonist (CGS21680). However, when okadaic acid (a relatively protein phosphatase 2A-specific phosphatase inhibitor) was added after agonist removal, adenylyl cyclase activity did not recover. Okadaic acid caused significant dose-dependent inhibition of adenylyl cyclase activity in intact PC-12 cells. Prolonged exposure of okadaic acid- treated PC-12 cells to adenosine agonists did not evoke further inhibition, suggesting that the inhibition of adenylyl cyclase activity during A2a desensitization may operate through a pathway that overlaps with the increased phosphorylation caused by okadaic acid. Inclusion of calcium in the adenylyl cyclase assay significantly inhibited cyclase activity. indicating that PC-12 cells contain Ca(2+)-inhibitable type VI adenylyl cyclase (AC6). This was confirmed by polymerase chain reaction-based detection of AC6 cDNA. Furthermore, incubation of PC-12 cell membrane fractions with purified protein phosphatase 2A or coexpression of protein phosphatase 2A with AC6 in COS-1 cells significantly increased AC6 activity. To reduce the possible influence of Gs alpha protein, we substituted guanosine-5'-O-(2-thio)diphosphate and MnCl2 for GTP and MgCl2, respectively, in some cyclase assays and found that the suppression of AC6 during A2a desensitization and okadaic acid treatment remained largely unchanged. Taken together, these data suggest that phosphorylation of AC6 might account for the inhibition of adenylyl cyclase activity during A2a desensitization in PC-12 cells.
This article has been cited by other articles:
![]() |
J. Che, E. S. L. Chan, and B. N. Cronstein Adenosine A2A Receptor Occupancy Stimulates Collagen Expression by Hepatic Stellate Cells via Pathways Involving Protein Kinase A, Src, and Extracellular Signal-Regulated Kinases 1/2 Signaling Cascade or p38 Mitogen-Activated Protein Kinase Signaling Pathway Mol. Pharmacol., December 1, 2007; 72(6): 1626 - 1636. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-l. Chou, C.-L. Huang, H.-L. Lai, A. C. Hung, C.-L. Chien, Y.-Y. Kao, and Y. Chern Regulation of Type VI Adenylyl Cyclase by Snapin, a SNAP25-binding Protein J. Biol. Chem., October 29, 2004; 279(44): 46271 - 46279. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Linden Autoregulation of Cyclic AMP in Vascular Smooth Muscle: A Role for Adenosine Receptors Mol. Pharmacol., November 1, 2002; 62(5): 969 - 970. [Full Text] [PDF] |
||||
![]() |
K. W. Miller The nature of sites of general anaesthetic action Br. J. Anaesth., July 1, 2002; 89(1): 17 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Sunahara and R. Taussig Isoforms of Mammalian Adenylyl Cyclase: Multiplicities of Signaling Mol. Interv., June 1, 2002; 2(3): 168 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Lin, H.-L. Lai, Y.-Y. Kao, C.-N. Sun, M.-J. Hwang, and Y. Chern Protein Kinase C Inhibits Type VI Adenylyl Cyclase by Phosphorylating the Regulatory N Domain and Two Catalytic C1 and C2 Domains J. Biol. Chem., May 3, 2002; 277(18): 15721 - 15728. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Zahniser, J. K. Simosky, R. D. Mayfield, C. A. Negri, T. Hanania, G. A. Larson, M. A. Kelly, D. K. Grandy, M. Rubinstein, M. J. Low, et al. Functional Uncoupling of Adenosine A2A Receptors and Reduced Response to Caffeine in Mice Lacking Dopamine D2 Receptors J. Neurosci., August 15, 2000; 20(16): 5949 - 5957. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Lai, T.-H. Lin, Y.-Y. Kao, W.-J. Lin, M.-J. Hwang, and Y. Chern The N Terminus Domain of Type VI Adenylyl Cyclase Mediates Its Inhibition by Protein Kinase C Mol. Pharmacol., September 1, 1999; 56(3): 644 - 650. [Abstract] [Full Text] |
||||
![]() |
C. Florio, F. Frausin, R. Vertua, and R. M. Gaion Amplification of the Cyclic AMP Response to Forskolin in Pheochromocytoma PC12 Cells through Adenosine A2A Purinoceptors J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 817 - 824. [Abstract] [Full Text] |
||||
![]() |
W.-J. Tang and J. H. Hurley Catalytic Mechanism and Regulation of Mammalian Adenylyl Cyclases Mol. Pharmacol., August 1, 1998; 54(2): 231 - 240. [Full Text] |
||||
![]() |
S. J. Mundell, J. L. Benovic, and E. Kelly A Dominant Negative Mutant of the G Protein-Coupled Receptor Kinase 2 Selectively Attenuates Adenosine A2 Receptor Desensitization Mol. Pharmacol., June 1, 1997; 51(6): 991 - 998. [Abstract] [Full Text] |
||||
![]() |
H.-L. Lai, T.-H. Yang, R. O. Messing, Y.-H. Ching, S.-C. Lin, and Y. Chern Protein Kinase C Inhibits Adenylyl Cyclase Type VI Activity during Desensitization of the A2a-Adenosine Receptor-mediated cAMP Response J. Biol. Chem., February 21, 1997; 272(8): 4970 - 4977. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-K. Huang, Y.-W. Lin, C.-L. Huang, R. O. Messing, and Y. Chern Activation of Protein Kinase A and Atypical Protein Kinase C by A2A Adenosine Receptors Antagonizes Apoptosis Due to Serum Deprivation in PC12 Cells J. Biol. Chem., April 20, 2001; 276(17): 13838 - 13846. [Abstract] [Full Text] [PDF] |
||||